This Thermo Scientific Chemicals brand product was originally part of the Acros Organics product portfolio. Some documentation and label information may refer to the legacy brand. The original Acros Organics product / item code or SKU reference has not changed as a part of the brand transition to Thermo Scientific Chemicals.
General description
- Doxycycline hyclate is a broad-spectrum bacteriostatic antibiotic of the tetracycline class
- Doxycycline inhibits bacterial growth by preventing polypeptide formation via inhibition of at least one ribosomal subunit
- Known to reversibly bind the 30S ribosomal subunit and inhibit formation of the aminoacyl-tRNA/mRNA-ribosome complex
- Inhibits matrix metalloproteinases in many microorganisms
Applications
- Effective against the bacteria that cause Lyme disease, chlamydia, rickettsia and mycoplasma; suitable for antibiotic resistance testing and study of cellular mechanisms
- Intended for laboratory use only
RUO – Research Use Only
Literature references: Adrian, J.; Fernández, F.; Sánchez-Baeza, F.; Marco, M. P. Preparation of antibodies and development of an enzyme-linked immunosorbent assay (ELISA) for the determination of doxycycline antibiotic in milk samples. J Agric Food Chem. 2012, 60(15), 3837-46.Aleksic, T.; Baumann, B., Wagner, M.; Adler, G.; Wirth, T.; Weber, C. K. Cellular immune reaction in the pancreas is induced by constitutively active IkappaB kinase-2. Gut. 2007, 56(2), 227-36. Moore, A. L.; desJardins-Park, H. E.; Duoto, B. A.; Mascharak, S.; Murphy, M. P.; Irizarry, D. M.; Foster, D. S.; Jones, R. E.; Barnes, L. A.; Marshall, C. D; Ransom, R. C.; Wernig, G.; Longaker, M. T. Doxycycline Reduces Scar Thickness and Improves Collagen Architecture. Ann Surg. 2020, 272(1),183-193. Doxycycline host-directed therapy in human pulmonary tuberculosis.Miow Q. H.; Vallejo A. F.; Wang Y; Hong J. M.; Bai C., Teo F. S.; Wang A. D.; Loh H. R.; Tan T. Z.; Ding Y., She H. W.; Gan S. H.; Paton N. I.; Lum J.; Tay A.; Chee C. B.; Tambyah P. A.; Polak M. E.; Wang Y. T.; Singhal A.; Elkington P. T.; Friedland J. S.; Ong C. W. J Clin Invest. 2021 Aug 2;131(15):e141895. doi: 10.1172/JCI141895.